Global Oncology Devices Research Report 2022-2023 & 2029 - Enhanced Reimbursement Policies Fostering Demand Growth


Dublin, Aug. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Oncology Devices Market (2023 Edition): Analysis By Device Type (Ablation, Embolization, Others), Cancer Type (Breast, Uterine, Colon and Rectum, Prostate, Others), By Application, By Region, By Country: Drivers, Trends and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

The Global Oncology Devices Market is poised for a significant transformation, projected to surge to a remarkable value of $217 billion by the conclusion of 2029, marking a substantial leap from its valuation of $69.80 billion in 2022.

Anticipated to flourish at an impressive CAGR of 18.05% during the forecast span from 2024 to 2029, the Global Oncology Devices market exhibits robust growth prospects.

This surge is underpinned by a comprehensive research report that delves into the intricacies of various regions, including the Americas, Europe, APAC, and the Middle East Africa, as well as an analysis of 10 influential countries including the United States, Canada, United Kingdom, Germany, France, Italy, Spain, China, India, and Japan.

The report intricately unfolds market dynamics such as size, annual growth, potential analysis, competitive landscape, investment opportunities, and demand forecasts. The scope of the oncology devices market is vast, encompassing an array of medical devices dedicated to the detection, treatment, and management of cancer.

These devices span imaging, biopsy, radiation therapy, surgical tools, and more. Given that cancer remains a significant contributor to global mortality and morbidity, the surge in demand for these oncology devices becomes increasingly apparent, shaping the market's trajectory.

The primary driver of the Oncology Devices market is the rising incidence of cancer worldwide, which is primarily attributable to an aging population, sedentary lifestyles, environmental factors, and genetic predisposition. Increasing cancer awareness and early detection measures have resulted in higher cancer screening rates. This has increased the demand for oncology devices used for early cancer detection and staging.

Moreover, accelerated technological developments have transformed the diagnosis and therapy of cancer. Novel medical devices, such as molecular testing, targeted treatments, and immunotherapies, which have improved outcomes for patients and expanded treatment options, which is driving market growth.

Key Attributes:

Report AttributeDetails
No. of Pages270
Forecast Period2023 - 2029
Estimated Market Value in 2023137.67 Billion
Forecasted Market Value by 2029401.85 Billion
Compound Annual Growth Rate17.0%
Regions CoveredGlobal

Strategic Recommendations

  • Robot-assisted surgery devices for Cancer
  • Adoption of improved reimbursement policies to support the demand of Oncology devices market

Report Highlights

  • Impact Analysis of Macro Economic Factors on Oncology Devices Market
  • PET/CT price in Select countries, In EUR
  • Radiation therapy price, in Select Countries, in EUR
  • Radiofrequency ablation prices, in Select Countries, in EUR
  • Age-standardised cancer incidence rate, 2020
  • Oncology Devices in Pipeline
  • Global Oncology Devices Market: Dashboard
  • Global Oncology Devices Market: Market Value Assessment, 2019-2029 (USD Billion)
  • Impact of COVID-19 on Global Oncology Devices Market

Global Oncology Devices Market Historic and Forecast (2019-2029)

Global Oncology Devices Market Segmentation: By Device Type

  • Global Oncology Devices Market, By Device Type Type Overview
  • Global Oncology Devices Market Size, By Ablation Devices, By Value, 2019H-2029F (USD Billion & CAGR)
  • Global Oncology Devices Market Size, By Embolization devices, By Value, 2019H-2029F (USD Billion & CAGR)
  • Global Oncology Devices Market Size, By Other Devices, By Value, 2019H-2029F (USD Billion & CAGR)

Global Oncology Devices Market Segmentation: By Cancer Type

  • Global Oncology Devices Market, By Cancer Type Overview
  • Global Oncology Devices Market Size, By Breast cancer, By Value, 2019H-2029F (USD Billion & CAGR)
  • Global Oncology Devices Market Size, By Uterine cancer, By Value, 2019H-2029F (USD Billion & CAGR)
  • Global Oncology Devices Market Size, By Colon and rectum cancer, By Value, 2019H-2029F (USD Billion & CAGR)
  • Global Oncology Devices Market Size, By Prostate cancer, By Value, 2019H-2029F (USD Billion & CAGR)
  • Global Oncology Devices Market Size, By Other Cancer Types, By Value, 2019H-2029F (USD Billion & CAGR)

Global Oncology Devices Market Segmentation: By Application

  • Global Oncology Devices Market, By Application Overview
  • Global Oncology Devices Market Size, By Chemotherapy, By Value, 2019H-2029F (USD Billion & CAGR)
  • Global Oncology Devices Market Size, By Radiation, By Value, 2019H-2029F (USD Billion & CAGR)
  • Global Oncology Devices Market Size, By Surgical, By Value, 2019H-2029F (USD Billion & CAGR)
  • Global Oncology Devices Market Size, By Diagnosis, By Value, 2019H-2029F (USD Billion & CAGR)

Competitive Positioning

  • Companies' Product Positioning
  • Market Position Matrix
  • Market Share Analysis of Oncology Devices Market

Company Profiles

  • Abbott Laboratories
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • GE HealthCare Technologies Inc
  • Elekta AB
  • Medtronic PLC
  • BEBIG Medical GmbH
  • Theragenics Corporation

For more information about this report visit https://www.researchandmarkets.com/r/5oxa59

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

 
Global Oncology Devices Market

Contact Data